FTXH vs. IHE
Compare and contrast key facts about First Trust Nasdaq Pharmaceuticals ETF (FTXH) and iShares U.S. Pharmaceuticals ETF (IHE).
FTXH and IHE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FTXH is a passively managed fund by First Trust that tracks the performance of the Nasdaq U.S. Smart Pharmaceuticals Index. It was launched on Sep 20, 2016. IHE is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Pharmaceuticals Index. It was launched on May 5, 2006. Both FTXH and IHE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FTXH or IHE.
Key characteristics
| FTXH | IHE | |
|---|---|---|
| YTD Return | -2.22% | 2.77% |
| 1Y Return | -2.40% | 7.95% |
| 3Y Return (Ann) | 1.00% | 6.67% |
| 5Y Return (Ann) | 5.93% | 10.31% |
| Sharpe Ratio | -0.13 | 0.65 |
| Daily Std Dev | 12.54% | 13.46% |
| Max Drawdown | -32.11% | -35.30% |
| Current Drawdown | -8.17% | -8.68% |
Correlation
The correlation between FTXH and IHE is 0.72, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FTXH vs. IHE - Performance Comparison
In the year-to-date period, FTXH achieves a -2.22% return, which is significantly lower than IHE's 2.77% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FTXH vs. IHE - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is higher than IHE's 0.42% expense ratio.
Risk-Adjusted Performance
FTXH vs. IHE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FTXH vs. IHE - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.47%, less than IHE's 3.43% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.47% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.16% | 0.00% | 0.00% | 0.00% |
IHE iShares U.S. Pharmaceuticals ETF | 3.43% | 4.16% | 6.02% | 4.48% | 3.57% | 4.19% | 3.76% | 4.08% | 2.75% | 5.78% | 3.60% | 3.19% |
Drawdowns
FTXH vs. IHE - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum IHE drawdown of -35.30%. Use the drawdown chart below to compare losses from any high point for FTXH and IHE. For additional features, visit the drawdowns tool.
Volatility
FTXH vs. IHE - Volatility Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a higher volatility of 3.39% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 3.22%. This indicates that FTXH's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.